167 related articles for article (PubMed ID: 10442918)
1. Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists.
Ellis PM; Butow PN; Simes RJ; Tattersall MH; Dunn SM
Aust N Z J Surg; 1999 Jul; 69(7):486-91. PubMed ID: 10442918
[TBL] [Abstract][Full Text] [Related]
2. A population-based assessment of specialty physician involvement in cancer clinical trials.
Klabunde CN; Keating NL; Potosky AL; Ambs A; He Y; Hornbrook MC; Ganz PA
J Natl Cancer Inst; 2011 Mar; 103(5):384-97. PubMed ID: 21317382
[TBL] [Abstract][Full Text] [Related]
3. Barriers to participation in clinical trials: a physician survey.
Mahmud A; Zalay O; Springer A; Arts K; Eisenhauer E
Curr Oncol; 2018 Apr; 25(2):119-125. PubMed ID: 29719427
[TBL] [Abstract][Full Text] [Related]
4. Organizational and physician factors associated with patient enrollment in cancer clinical trials.
Jacobs SR; Weiner BJ; Reeve BB; Weinberger M; Minasian LM; Good MJ
Clin Trials; 2014 Oct; 11(5):565-75. PubMed ID: 24902923
[TBL] [Abstract][Full Text] [Related]
5. Barriers to Clinical Trial Accrual: Perspectives of Community-Based Providers.
Knelson LP; Cukras AR; Savoie J; Agarwal A; Guo H; Hu J; Fell G; Lederman R; Hughes ME; Winer EP; Lin NU; Tolaney SM
Clin Breast Cancer; 2020 Oct; 20(5):395-401.e3. PubMed ID: 32605813
[TBL] [Abstract][Full Text] [Related]
6. Assessing the medical workforces perceived barriers to the prescription of risk-reducing medication for women at high-risk of breast cancer.
Sutherland S; Meiser B; Kaur R; Mitchell G; Kirk J; Peate M; Tim Wong WK; Goodwin A
Breast J; 2019 Jan; 25(1):34-40. PubMed ID: 30525267
[TBL] [Abstract][Full Text] [Related]
7. Doctors' participation in randomized trials of adjuvant systemic therapy in breast cancer: how does it relate to their recommendations for standard therapy in breast cancer?
Ellis PM; Buttow PN; Simes RJ; Tattersall MH; Dunn SM; MacLeod C
Breast; 1999 Aug; 8(4):182-7. PubMed ID: 14731437
[TBL] [Abstract][Full Text] [Related]
8. Discordant attitudes and beliefs about cancer clinical trial participation between physicians, research staff, and cancer patients.
Hillyer GC; Beauchemin M; Hershman DL; Kelsen M; Brogan FL; Sandoval R; Schmitt KM; Reyes A; Terry MB; Lassman AB; Schwartz GK
Clin Trials; 2020 Apr; 17(2):184-194. PubMed ID: 32009456
[TBL] [Abstract][Full Text] [Related]
9. Views of American oncologists about the purposes of clinical trials.
Joffe S; Weeks JC
J Natl Cancer Inst; 2002 Dec; 94(24):1847-53. PubMed ID: 12488478
[TBL] [Abstract][Full Text] [Related]
10. Patient and physician attitudes toward breast cancer clinical trials: developing interventions based on understanding barriers.
Melisko ME; Hassin F; Metzroth L; Moore DH; Brown B; Patel K; Rugo HS; Tripathy D
Clin Breast Cancer; 2005 Apr; 6(1):45-54. PubMed ID: 15899072
[TBL] [Abstract][Full Text] [Related]
11. A survey of Australian and New Zealand clinical practice with neoadjuvant systemic therapy for breast cancer.
Zdenkowski N; Butow P; Mann GB; Fewster S; Beckmore C; Isaacs R; Douglas C; Boyle FM
Intern Med J; 2016 Jun; 46(6):677-83. PubMed ID: 26929045
[TBL] [Abstract][Full Text] [Related]
12. Effect of medical oncologists' attitudes on accrual to clinical trials in a community setting.
Somkin CP; Ackerson L; Husson G; Gomez V; Kolevska T; Goldstein D; Fehrenbacher L
J Oncol Pract; 2013 Nov; 9(6):e275-83. PubMed ID: 24151327
[TBL] [Abstract][Full Text] [Related]
13. Barriers to clinical trial participation as perceived by oncologists and patients.
Meropol NJ; Buzaglo JS; Millard J; Damjanov N; Miller SM; Ridgway C; Ross EA; Sprandio JD; Watts P
J Natl Compr Canc Netw; 2007 Sep; 5(8):655-64. PubMed ID: 17927923
[TBL] [Abstract][Full Text] [Related]
14. Attitudes of Canadian oncology practitioners toward psychosocial interventions in clinical and research settings in women with breast cancer.
Del Giudice ME; Leszcz M; Pritchard KI; Vincent L; Goodwin P
Psychooncology; 1997 Sep; 6(3):178-89. PubMed ID: 9313283
[TBL] [Abstract][Full Text] [Related]
15. Physicians' knowledge, attitude, and behavior regarding fertility issues for young breast cancer patients: a national survey for breast care specialists.
Shimizu C; Bando H; Kato T; Mizota Y; Yamamoto S; Fujiwara Y
Breast Cancer; 2013 Jul; 20(3):230-40. PubMed ID: 22271066
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trials in oncology: understanding and attitudes predict willingness to participate.
Ellis PM; Butow PN; Tattersall MH; Dunn SM; Houssami N
J Clin Oncol; 2001 Aug; 19(15):3554-61. PubMed ID: 11481363
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial discussion, referral, and recruitment: physician, patient, and system factors.
Kaplan CP; Nápoles AM; Dohan D; Shelley Hwang E; Melisko M; Nickleach D; Quinn JA; Haas J
Cancer Causes Control; 2013 May; 24(5):979-88. PubMed ID: 23420328
[TBL] [Abstract][Full Text] [Related]
18. Barriers to participation in cancer prevention clinical trials.
Hall MJ; Egleston B; Miller SM; Buzaglo JS; Millard J; Ridgway C; Damjanov N; Sprandio JD; Meropol NJ
Acta Oncol; 2010 Aug; 49(6):757-66. PubMed ID: 20515420
[TBL] [Abstract][Full Text] [Related]
19. Barriers to Australian physicians' and paediatricians' involvement in randomised controlled trials.
Caldwell PH; Craig JC; Butow PN
Med J Aust; 2005 Jan; 182(2):59-65. PubMed ID: 15651962
[TBL] [Abstract][Full Text] [Related]
20. Barriers to participation in randomized clinical trials for early breast cancer among Australian cancer specialists: comment.
Malycha P
Aust N Z J Surg; 1999 Sep; 69(9):677. PubMed ID: 10515345
[No Abstract] [Full Text] [Related]
[Next] [New Search]
